Prognostic Assessment
Prognostic Assessment - Related Videos
06:03
Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
0 Views •
Cited by 41 •
2020
Breast cancer related lymphedema is frequent in breast cancer survivors, but there are not widely employed guidelines for its diagnosis and quantification. Here, we introduce a reliable and cost-effective protocol to define, quantify, and compare upper limb volume in breast cancer patients.
08:08
Cell-based Assay Protocol for the Prognostic Prediction of Idiopathic Scoliosis Using Cellular Dielectric Spectroscopy
0 Views •
Cited by 8 •
2013
A structured protocol is presented for a cell-based assay as a functional test to predict the prognosis of idiopathic scoliosis using cellular dielectric spectroscopy (CDS). The assay can be performed with fresh or frozen peripheral blood mononuclear cells (PBMCs) and the procedure is completed within 4 days.
08:36
Neurotoxicity Assessment in Adult Danio rerio using a Battery of Behavioral Tests in a Single Tank
0 Views •
Cited by 3 •
2023
Here, we present a comprehensive behavioral test battery, including the novel tank, Shoaling, and social preference tests, to effectively determine the potential neurotoxic effects of chemicals (e.g., methamphetamine and glyphosate) on adult zebrafish using a single tank. This method is relevant to neurotoxicity and environmental research.
06:50
Systematic Assessment of Well-Being in Mice for Procedures Using General Anesthesia
0 Views •
Cited by 25 •
2018
We developed a protocol to assess well-being in mice during procedures using general anesthesia. A series of behavioral parameters indicating levels of well-being as well as glucocorticoid metabolites were analyzed. The protocol can serve as a general aid to estimate the degree of severity in a scientific, animal-centered manner.
07:08
Assessing and Flushing a Peripheral Intravenous Line
0 Views •
2023
Source: Madeline Lassche, MSNEd, RN and Katie Baraki, MSN, RN, College of Nursing, University of Utah, UT After peripheral intravenous (IV) access is initiated, it is important to assess and maintain the IV catheter according to institutional policies and nursing standards of practice. The regular assessment of the insertion site and the surrounding areas for signs of complications is necessary to prevent IV catheter complications, including infiltration, phlebitis, infection, extravasation, or...
FAQs
Clinical history, physical findings, diagnostic results, disease severity, and comorbidities provide patient-specific evidence about the likely course of illness. Validated prognostic models organize these factors to estimate risks such as progression, complications, recovery, or mortality. Considering both individualized information and structured models helps clinicians make more informed decisions than relying on any single finding alone.
Predictions describe likely risks, not guaranteed outcomes for an individual patient. The available findings and models can indicate the probability of progression, complications, recovery, or mortality, but they cannot eliminate uncertainty. Communicating these limits supports realistic discussions, prevents overinterpretation of estimates, and helps patients and clinicians weigh decisions in the context of changing clinical circumstances.
A patient’s disease severity, diagnostic findings, complications, or response to treatment may change over time, altering the expected course. Updating the assessment incorporates this new information and can reveal opportunities for timely intervention. Reassessment also keeps treatment planning, follow-up scheduling, and discussions about likely outcomes aligned with the patient’s current clinical status.
The process draws on the patient’s clinical history, physical findings, diagnostic test results, disease severity, and comorbidities. Clinicians may also apply validated prognostic models to integrate these factors and estimate relevant risks. Reviewing this information systematically provides a basis for individualized treatment planning and helps determine which outcomes or complications require closer attention.
Risk estimates can help clinicians tailor treatment decisions to the patient’s expected disease course and response to therapy. They can also guide the timing and intensity of follow-up, particularly when the assessment indicates risk of progression or complications. Because the assessment can change, ongoing review allows plans to be adjusted as new clinical information becomes available.
By presenting likely outcomes alongside their uncertainty, clinicians can support discussions that reflect the patient’s circumstances and available treatment choices. The assessment may also help identify opportunities for timely intervention and inform allocation of healthcare resources. Its value extends beyond prediction because it connects risk information with communication, planning, and decisions about ongoing care.